Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAptitude Regulatory News (APTD)

Share Price Information for Aptitude (APTD)

Share Price is delayed by 15 minutes
Get Live Data
222.00    0.00 (0.00%)
Bid:
222.00
Ask:
232.00
Spread: 10.00 (4.505%)
Market Cap: £117.21m
APTD Live PriceLast checked at - London Stock Exchange

Intraday Aptitude Share Chart

Form 8 (OPD) Microgen plc

11 Jun 2014 09:34

ABERFORTH PARTNERS LLP - Form 8 (OPD) Microgen plc

ABERFORTH PARTNERS LLP - Form 8 (OPD) Microgen plc

PR Newswire

London, June 11

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Identity of the person whose positions/ Aberforth Partners LLP, ondealings are being disclosed: behalf of discretionary clients. (b) Owner or controller of interests and shortpositions disclosed, if different from 1(a): The naming of nominee or vehicle companies isinsufficient (c) Name of offeror/offeree in relation to Microgen plcwhose relevant securities this form relates: Use a separate form for each offeror/offeree (d) If an exempt fund manager connected withan offeror/offeree, state this and specifyidentity of offeror/offeree: (e) Date position held/dealing undertaken: 26 May 2014 (f) Has the discloser previously disclosed, or Y/N - NOare they today disclosing, under the Code inrespect of any other party to this offer? If YES, specify which: 2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE (a) Interests and short positions in the relevant securities of the offeror orofferee to which the disclosure relates following the dealing (if any) Class of relevant security: Ordinary Shares Interests Short positions Number % Number % (1) Relevant securities owned 15,777,814 21.18 0 0.0and/or controlled: (2) Derivatives (other thanoptions): (3) Options and agreements topurchase/sell: TOTAL: 15,777,814 21.18 0 0.0 Aberforth Partners LLP does not have discretion regarding voting decisions inrespect of 6,201,206 shares included in the total disclosed above All interests and all short positions should be disclosed. Details of any open derivative or option positions, or agreements to purchaseor sell relevant securities, should be given on a Supplemental Form 8 (OpenPositions). (b) Rights to subscribe for new securities (including directors' and otherexecutive options) Class of relevant security in N/Arelation to which subscription rightexists: Details, including nature of the N/Arights concerned and relevantpercentages: If there are positions or rights to subscribe to disclose in more than oneclass of relevant securities of the offeror or offeree named in 1(c), copytable 2(a) or (b) (as appropriate) for each additional class of relevantsecurity. 3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE (a) Purchases and sales Class of relevant Purchase/sale Number of Price per unit security securities N/A- OpeningDisclosure (b) Derivatives transactions (other than options) Class of Product Nature of dealing Number of Price per relevant description reference unit security e.g. opening/closing a securities e.g. CFD long/short position, increasing/reducing a long/short position N/A (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Class of Product Writing, Number of Exercise Type Expiry Optionrelevant description purchasing, securities price date moneysecurity e.g. call selling, to which per unit e.g. paid/ option varying option American, received etc. relates European per unit etc. N/A (ii) Exercising Class of relevant Product Number of Exercise price per security description securities unit e.g. call option N/A (d) Other dealings (including subscribing for new securities) Class of relevant Nature of dealing Details Price per unit security (if applicable) e.g. subscription, conversion N/A The currency of all prices and other monetary amounts should be stated. Where there have been dealings in more than one class of relevant securities ofthe offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (asappropriate) for each additional class of relevant security dealt in. 4. OTHER INFORMATION (a) Indemnity and other dealing arrangements Details of any indemnity or option arrangement, or any agreement orunderstanding, formal or informal, relating to relevant securities which maybe an inducement to deal or refrain from dealing entered into by the personmaking the disclosure and any party to the offer or any person acting inconcert with a party to the offer: If there are no such agreements, arrangements or understandings, state "none" None (b) Agreements, arrangements or understandings relating to options orderivatives Details of any agreement, arrangement or understanding, formal or informal,between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevantsecurities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state "none" None (c) Attachments Is a Supplemental Form 8 (Open Positions) attached? Y/N NO Date of disclosure: 27 May 2014 (amended 11 June 2014) Contact name: David Holland, for Aberforth Partners LLP Telephone number: 0131 220 0733 Public disclosures under Rule 8 of the Code must be made to a RegulatoryInformation Service and must also be emailed to the Takeover Panel atmonitoring@disclosure.org.uk . The Panel's Market Surveillance Unit isavailable for consultation in relation to the Code's dealing disclosurerequirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk .

Date   Source Headline
11th Apr 20163:50 pmRNSHolding(s) in Company
30th Mar 20163:55 pmRNSBlocklisting Interim Review
30th Mar 20163:52 pmRNSTotal Voting Rights
22nd Mar 201610:07 amRNSHolding(s) in Company
21st Mar 20164:18 pmRNSHolding(s) in Company
15th Mar 20164:41 pmRNSHolding(s) in Company
15th Mar 20164:34 pmRNSHolding(s) in Company
15th Mar 20164:30 pmRNSHolding(s) in Company
14th Mar 201612:51 pmRNSHolding(s) in Company
3rd Mar 20167:00 amRNSPreliminary Results
26th Jan 20167:00 amRNSBusiness Update & Notice of Results
14th Jan 20163:29 pmRNSBlocklisting Interim Review
7th Jan 20169:39 amRNSHolding(s) in Company
29th Dec 20159:17 amRNSHolding(s) in Company
5th Nov 201510:12 amRNSProperty Disposal
2nd Nov 201510:10 amRNSHolding(s) in Company
29th Oct 20155:21 pmRNSHolding(s) in Company
27th Oct 20154:14 pmRNSHolding(s) in Company
27th Oct 201510:00 amRNSTotal Voting Rights
22nd Oct 201512:29 pmRNSDirector/PDMR Shareholding
22nd Oct 20157:01 amRNSDirector/PDMR Shareholding
22nd Oct 20157:00 amRNSTrading Update and Board Changes
29th Sep 20157:01 amRNSBlocklisting Interim Review
28th Aug 20159:52 amRNSTotal Voting Rights
22nd Jul 20155:46 pmRNSBlocklisting return
16th Jul 20157:02 amRNSInterim Results
16th Jul 20157:00 amRNSAcquisition of Jobstream Group Limited
15th Jul 20151:22 pmRNSNotice of Results
9th Jun 20157:00 amRNSAcquisition
18th May 20159:58 amRNSResult of AGM
18th May 20157:00 amRNSAGM Trading Update
29th Apr 201512:26 pmRNSHolding(s) in Company
30th Mar 20155:49 pmRNSBlocklisting Interim Review
19th Mar 20157:00 amRNSReturn of Value and Listing of New Ordinary Shares
18th Mar 201511:23 amRNSResults of General Meeting
6th Mar 201512:22 pmRNSHolding(s) in Company
26th Feb 20153:39 pmRNSHolding(s) in Company
25th Feb 20152:26 pmRNS2014 Final Dividend
25th Feb 20157:02 amRNSReturn of Value
25th Feb 20157:01 amRNSPreliminary Results
28th Jan 20152:02 pmRNSHolding(s) in Company
23rd Jan 20151:17 pmRNSHolding(s) in Company
23rd Jan 20157:00 amRNSTrading Update
21st Jan 201512:14 pmRNSDirector Declaration
5th Jan 20157:00 amRNSBlocklisting Interim Review
5th Dec 20147:00 amRNSAcquisition
3rd Nov 20147:00 amRNSTotal Voting Rights
30th Oct 20147:00 amRNSInterim Management Statement
7th Oct 20142:28 pmRNSAdditional Listing
30th Sep 20142:47 pmRNSBlocklisting Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.